Refresh Checked Unchecked Menu Search Shopping bag Geolocation Person Facebook Instagram Twitter YouTube Info Icon CBC Icon CBC Shape CBD Icon CBD Shape CBG Icon CBG Shape THC Icon THC Shape THCV Icon THCV Shape Loading…
Advertise on Leafly

California Company to Begin Testing Cannabis Breathalyzer

December 9, 2015

For many voters still wary of cannabis legalization, driving under the influence is a major sticking point. A California company hopes to address that concern by offering police a roadside test to check drivers for impairment, just as they do for alcohol.

A cannabis breathalyzer will undergo clinical trials early next year, according to Oakland-based Hound Labs, which developed the technology in collaboration with scientists at UC Berkeley. If all goes well, the company hopes to make the device available to consumers and law enforcement by the end of 2016.

“In just one or two breaths, our new scientific approach is able to capture THC, and, through an extraction process, measure the actual level to less than 500 picograms,” Matt Francis, a UC Berkeley professor and associate dean of chemistry, said in a statement.

Instant measurement to within half a nanogram could be a big help to officers, who are often left guessing whether a driver is impaired. State law in Washington, for example, limits drivers to 5 nanograms of active THC per milliliter of blood — but there’s no way to test that level on the spot.

For now, police have to rely on blood tests, which require that the driver be arrested and a warrant issued to collect blood. Other testing methods, such as saliva or urine tests, can reveal past cannabis use but don’t indicate whether a driver is actually impaired.

“We need a way to not only test ‘yes’ or ‘no’ for the presence of marijuana, but to actually measure and correlate THC levels with impairment,” said Hound Labs CEO Mike Lynn, an emergency room physician.

Measuring blood levels is one thing, judging impairment is another. Regardless of whether the device is a success in trials, many cannabis advocates point out that THC levels don’t give a good indication of a user’s impairment. Even the National Highway Traffic Safety Administration acknowledges that it’s “difficult to establish a relationship between a person’s THC blood or plasma concentration and performance impairing effects.”

UPDATE: NPR has the latest on a similar effort unfolding at Washington State University.

  • A breathalyzer may be able to measure the levels of THC in the blood to 500 picograms, however there is no accounting for the individual. Each person (patient) has their own condition, and therefore dosage. With each dosage comes a level of tolerance to the drug. A patient that uses a high dose will develop a higher tolerance, and it will not have the same cognitive effect, and therefore impairments to driving, as with a person who has a much lower intake of cannabis. This principle is the same, and can be applied to many pharmaceutical drugs on the market that have the potential to impair driving.